Trial intelligence / Profile preview

Comparison of morphine and alfentanil in the emergency treatment of severe acute pain in the pre-hospital setting

2025-522817-50-00Phase 4Authorised

Sponsor
CHU de Martinique
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Morphine arm with Rapifen arm (2 arms). Primary endpoint: Proportion of patients with pain level ≤ 3/10 at 15 minutes. Planned start Nov 2025; status: authorised.

02

Drugs

morphinealfentanil

Beyond the preview

Go deeper on 2025-522817-50-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-522817-50-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call